Organization · Corporate Venture Capital
Rex Health Ventures
Rex Health Ventures is an early-stage investment fund based in Raleigh, North Carolina, focused on advancing healthcare through investments in emerging companies and technologies. Established in 2012 by UNC REX Healthcare, it operates as part of the UNC Health System.
Overview
What Rex Health Ventures does
What Rex Health Ventures is
Rex Health Ventures is an early-stage investment fund based in Raleigh, North Carolina, focused on advancing healthcare through investments in emerging companies and technologies. Established in 2012 by UNC REX Healthcare, it operates as part of the UNC Health System.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Founded
- Founded in 2012
- Approximate age
- About 14 years
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find Rex Health Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Rex Health Ventures as a funder
Investment thesis
Rex Health Ventures invests in and partners with healthcare entrepreneurs to advance new treatments, tools, products, and services that improve patient care, leveraging strategic insights from the UNC Health System.
Focus narrative
RHV invests in healthcare-related companies and technologies, emphasizing strategic value beyond capital. The organization provides portfolio companies access to UNC REX and UNC Health expertise, healthcare operators, market feedback, and potential validation within a health-system context.
Value beyond capital
Rex Health Ventures adds value to its portfolio companies by providing access to a network of healthcare experts, insights into clinical workflows, and potential pilot validation within the UNC Health System. This strategic support enhances the likelihood of successful product adoption and market entry.
Terms and economics
- Typical check
- $250,000–$500,000
Focus and fit
- Stages
- Seed · Series A · Series B
- Sectors
- Healthcare · Biotech · Medical Devices · Digital Health
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
- Recorded notable exits
- BardyDX, Gauss Surgical, Kit Check, Phynd, Target PharmaSolutions, and Veran Medical Technologies
Portfolio context
Arrivo Bioventures: Developing biologics and small molecules to improve patient lives. Baebies: Innovative products for newborn screening and pediatric testing, including the FDA-authorized SEEKER® platform. Bio 54: Drug/device combination product for treating excessive bleeding in patients on anticoagulants. Censinet: Platform for managing third-party risk in healthcare organizations. Emergo Therapeutics: Treatments targeting inflammatory molecules. Leiters: FDA-registered provider of compounded sterile preparations and pharmacy services. Phononic: Solid-state thermal management solutions for cooling and heating applications. Pryon: AI company enhancing enterprise knowledge and workflow. Rediscovery: Improving outcomes for patients with Acute Kidney Injury. Vergent Bioscience: Imaging agents for minimally invasive surgeries.
Common questions
What to know about Rex Health Ventures
Upseed classifies Rex Health Ventures under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.